Innovative Biomarkers of Cardiovascular Complications Associated With Second-generation Bruton Tyrosine Kinase Inhibitor Treatments: a Single-center Cohort Study

Name: Innovative Biomarkers of Cardiovascular Complications Associated With Second-generation Bruton Tyrosine Kinase Inhibitor Treatments: a Single-center Cohort Study
License: Public Domain

Centre Hospitalier Universitaire Dijon

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

treatment with second-generation bruton's tyrosine kinase inhibitors (acalabrutinib, zanubrutinib)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 261369
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.